Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lord

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Psychophysiology|February 22, 2023
Evaluating EEG complexity metrics as biomarkers for depressionBrian Lord, John J B Allen
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|December 21, 2024
Enhancing Equanimity With Noninvasive Brain Stimulation: A Novel Framework for Mindfulness InterventionsBrian Lord, John J B Allen, Shinzen Young, et al.
European Journal of Pharmacology|July 23, 2013
Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampusBrian Lord, Cindy Wintmolders, Xavier Langlois, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2009
Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortexYing Qu, Leah Aluisio, Brian Lord, et al.
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|September 8, 2009
Developing and validating a sham acupuncture needleElizabeth A Tough, Adrian R White, Suzanne H Richards, et al.
Cell Reports|January 24, 2019
α6-Containing Nicotinic Acetylcholine Receptor Reconstitution Involves Mechanistically Distinct Accessory ComponentsShenyan Gu, Jose A Matta, Weston B Davini, et al.
Neuropharmacology|April 7, 2009
JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognitionRuggero Galici, Jamin D Boggs, Leah Aluisio, et al.
Frontiers in Pharmacology|April 6, 2019
<i>In vivo</i> Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 AgonistJames R Shoblock, Natalie Welty, Ian Fraser, et al.
European Journal of Pharmacology|June 13, 2020
Putative role of GPR139 on sleep modulation using pharmacological and genetic rodent modelsLien Wang, Christine Dugovic, Sujin Yun, et al.
Plos One|June 25, 2011
Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmissionPascal Bonaventure, Leah Aluisio, James Shoblock, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Psychophysiology|February 22, 2023
Evaluating EEG complexity metrics as biomarkers for depressionBrian Lord, John J B Allen
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|December 21, 2024
Enhancing Equanimity With Noninvasive Brain Stimulation: A Novel Framework for Mindfulness InterventionsBrian Lord, John J B Allen, Shinzen Young, et al.
European Journal of Pharmacology|July 23, 2013
Comparison of the ex vivo receptor occupancy profile of ketamine to several NMDA receptor antagonists in mouse hippocampusBrian Lord, Cindy Wintmolders, Xavier Langlois, et al.
Pharmacology, Biochemistry, and Behavior|May 26, 2009
Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortexYing Qu, Leah Aluisio, Brian Lord, et al.
Acupuncture in Medicine : Journal of the British Medical Acupuncture Society|September 8, 2009
Developing and validating a sham acupuncture needleElizabeth A Tough, Adrian R White, Suzanne H Richards, et al.
Cell Reports|January 24, 2019
α6-Containing Nicotinic Acetylcholine Receptor Reconstitution Involves Mechanistically Distinct Accessory ComponentsShenyan Gu, Jose A Matta, Weston B Davini, et al.
Neuropharmacology|April 7, 2009
JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognitionRuggero Galici, Jamin D Boggs, Leah Aluisio, et al.
Frontiers in Pharmacology|April 6, 2019
<i>In vivo</i> Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 AgonistJames R Shoblock, Natalie Welty, Ian Fraser, et al.
European Journal of Pharmacology|June 13, 2020
Putative role of GPR139 on sleep modulation using pharmacological and genetic rodent modelsLien Wang, Christine Dugovic, Sujin Yun, et al.
Plos One|June 25, 2011
Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmissionPascal Bonaventure, Leah Aluisio, James Shoblock, et al.
Pageof 7